Deutsche Bank Ag\ Logic Bio Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$4.03 - $7.57 $43,177 - $81,104	-10,714 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$6.8 - $9.16 $6,847 - $9,224	-1,007 Reduced 8.59%	10,714 $77,000
Q4 2020 Feb 16, 2021	BUY	$5.29 - $9.1 $24,762 - $42,597	4,681 Added 66.49%	11,721 $90,000
Q3 2020 Nov 12, 2020	BUY	$5.41 - $9.45 $3,164 - $5,528	585 Added 9.06%	7,040 $64,000
Q2 2020 Aug 13, 2020	BUY	$4.25 - $8.46 $15,334 - $30,523	3,608 Added 126.73%	6,455 $55,000
Q1 2020 May 14, 2020	SELL	$4.06 - $11.0 $10,783 - $29,216	-2,656 Reduced 48.26%	2,847 $14,000
Q4 2019 Feb 14, 2020	BUY	$7.01 - $11.01 $21,695 - $34,075	3,095 Added 128.53%	5,503 $38,000
Q3 2019 Nov 14, 2019	SELL	$6.97 - $13.46 $28,702 - $55,428	-4,118 Reduced 63.1%	2,408 $24,000
Q2 2019 Aug 14, 2019	SELL	$9.77 - $17.08 $36,012 - $62,956	-3,686 Reduced 36.09%	6,526 $83,000
Q1 2019 May 15, 2019	SELL	$7.93 - $10.41 $7,739 - $10,160	-976 Reduced 8.72%	10,212 $99,000
Q4 2018 Feb 14, 2019	BUY	$7.88 - $17.98 $88,161 - $201,160	11,188 New	11,188 $115,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.